Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Cipla
Baxter
Daiichi Sankyo
Merck
Federal Trade Commission
Fish and Richardson
Cerilliant
Dow
McKesson

Generated: January 24, 2018

DrugPatentWatch Database Preview

POLYCILLIN-N Drug Profile

« Back to Dashboard

When do Polycillin-n patents expire, and when can generic versions of Polycillin-n launch?

Polycillin-n is a drug marketed by Bristol and is included in one NDA.

The generic ingredient in POLYCILLIN-N is ampicillin sodium. There are sixty-nine drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the ampicillin sodium profile page.
Drug patent expirations by year for POLYCILLIN-N
Medical Subject Heading (MeSH) Categories for POLYCILLIN-N

US Patents and Regulatory Information for POLYCILLIN-N

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol POLYCILLIN-N ampicillin sodium INJECTABLE;INJECTION 050309-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol POLYCILLIN-N ampicillin sodium INJECTABLE;INJECTION 050309-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol POLYCILLIN-N ampicillin sodium INJECTABLE;INJECTION 050309-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol POLYCILLIN-N ampicillin sodium INJECTABLE;INJECTION 050309-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol POLYCILLIN-N ampicillin sodium INJECTABLE;INJECTION 050309-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Federal Trade Commission
Cerilliant
Boehringer Ingelheim
Chinese Patent Office
Covington
Deloitte
Cipla
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot